» Articles » PMID: 23042978

Environmental Risk Factors for Pneumocystis Pneumonia Hospitalizations in HIV Patients

Overview
Journal Clin Infect Dis
Date 2012 Oct 9
PMID 23042978
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pneumocystis pneumonia (PcP) is the second leading cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients in the United States. Although the host risk factors for the development of PcP are well established, the environmental (climatological, air pollution) risk factors are poorly understood. The major goal of this study was to determine the environmental risk factors for admissions of HIV-positive patients with PcP to a single medical center.

Methods: Between 1997 and 2008, 457 HIV-positive patients with microscopically confirmed PcP were admitted to the San Francisco General Hospital. A case-crossover design was applied to identify environmental risk factors for PcP hospitalizations. Climatological and air pollution data were collected from the Environmental Protection Agency and Weather Warehouse databases. Conditional logistic regression was used to evaluate the association of each environmental factor and PcP hospital admission.

Results: Hospital admissions were significantly more common in the summer than in the other seasons. Increases in temperature and sulfur dioxide levels were independently associated with hospital admissions for PcP, but the effects of sulfur dioxide were modified by increasing carbon monoxide levels.

Conclusions: This study identifies both climatological and air pollution constituents as independent risk factors for hospitalization of HIV-positive patients with PcP in San Francisco. Thus, the environmental effects on PcP are more likely complex than previously thought. Further studies are needed to understand how these factors exert their effects and to determine if these factors are associated with PcP in other geographic locations.

Citing Articles

COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.

Byanova K, Abelman R, North C, Christenson S, Huang L Int J Chron Obstruct Pulmon Dis. 2023; 18:2795-2817.

PMID: 38050482 PMC: 10693779. DOI: 10.2147/COPD.S388142.


Air pollution and respiratory infections: the past, present, and future.

Monoson A, Schott E, Ard K, Kilburg-Basnyat B, Tighe R, Pannu S Toxicol Sci. 2023; 192(1):3-14.

PMID: 36622042 PMC: 10025881. DOI: 10.1093/toxsci/kfad003.


Environmental Risk Factors for Talaromycosis Hospitalizations of HIV-Infected Patients in Guangzhou, China: Case Crossover Study.

Wang Y, Deng K Front Med (Lausanne). 2021; 8:731188.

PMID: 34881254 PMC: 8645774. DOI: 10.3389/fmed.2021.731188.


No Change of Pneumonia after the COVID-19 Pandemic: Multicenter Time-Series Analyses.

Kim D, Kim S, Jeon S, Kim S, Lee K, Lee H J Fungi (Basel). 2021; 7(11).

PMID: 34829277 PMC: 8624436. DOI: 10.3390/jof7110990.


Transmission and Colonization of .

Vera C, Rueda Z J Fungi (Basel). 2021; 7(11).

PMID: 34829266 PMC: 8622989. DOI: 10.3390/jof7110979.


References
1.
Carracedo-Martinez E, Taracido M, Tobias A, Saez M, Figueiras A . Case-crossover analysis of air pollution health effects: a systematic review of methodology and application. Environ Health Perspect. 2010; 118(8):1173-82. PMC: 2920078. DOI: 10.1289/ehp.0901485. View

2.
Varela J, Regordan C, Medrano F, Respaldiza N, de la Horra C, Montes-Cano M . Climatic factors and Pneumocystis jiroveci infection in southern Spain. Clin Microbiol Infect. 2004; 10(8):770-2. DOI: 10.1111/j.1469-0691.2004.00937.x. View

3.
Spektor D, Lippmann M, Thurston G, Lioy P, Stecko J, OConnor G . Effects of ambient ozone on respiratory function in healthy adults exercising outdoors. Am Rev Respir Dis. 1988; 138(4):821-8. DOI: 10.1164/ajrccm/138.4.821. View

4.
Kampa M, Castanas E . Human health effects of air pollution. Environ Pollut. 2007; 151(2):362-7. DOI: 10.1016/j.envpol.2007.06.012. View

5.
Burnett R, Brook J, Yung W, Dales R, Krewski D . Association between ozone and hospitalization for respiratory diseases in 16 Canadian cities. Environ Res. 1997; 72(1):24-31. DOI: 10.1006/enrs.1996.3685. View